Garg PK, Putegnat B, Truong L, et al. Visual interpretation, not SUV ratios, is the ideal method to interpret 18F-DOPA PET scans to aid in the cure of patients with focal congenital hyperinsulinism. PLoS One. 2020;15(10):e0241243. Published 2020 Oct 27. DOI: 10.1371/journal.pone.0241243
https://pubmed.ncbi.nlm.nih.gov/33108363/
Kathryn White 1, Lisa Truong 2, Kimberly Aaron 3, Nasir Mushtaq 4, Paul S Thornton 2 The Incidence and Etiology of Previously Undiagnosed Hypoglycemic Disorders in the Emergency Department
PMID: 30365409
DOI: 10.1097/PEC.0000000000001634
https://pubmed.ncbi.nlm.nih.gov/30365409/
Paul Thornton 1, Lisa Truong 1, Courtney Reynolds 2 3, Tyler Hamby 4, Jonathan Nedrelow 5 Rate of Serious Adverse Events Associated with Diazoxide Treatment of Patients with Hyperinsulinism
PMID: 30889588
DOI: 10.1159/000497458
https://pubmed.ncbi.nlm.nih.gov/30889588/
Paul S Thornton 1, Charles A Stanley 2, Diva D De Leon 2, Deborah Harris 3, Morey W Haymond 4, Khalid Hussain 5, Lynne L Levitsky 6, Mohammad H Murad 7, Paul J Rozance 8, Rebecca A Simmons 9, Mark A Sperling 10, David A Weinstein 11, Neil H White 12, Joseph I Wolfsdorf 13, Pediatric Endocrine Society Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children
PMID: 25957977
DOI: 10.1016/j.jpeds.2015.03.057
https://pubmed.ncbi.nlm.nih.gov/25957977/
Pradeep K Garg 1, Stephen J Lokitz 1, Lisa Truong 2, Burton Putegnat 2, Courtney Reynolds 2, Larry Rodriguez 2, Rachid Nazih 1, Jonathan Nedrelow 2, Miguel de la Guardia 2, John K Uffman 2, Sudha Garg 1, Paul S Thornton 2 Pancreatic uptake and radiation dosimetry of 6-[18F]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism
PMID: 29117181
PMCID: PMC5695579
DOI: 10.1371/journal.pone.0186340
https://pubmed.ncbi.nlm.nih.gov/29117181/
Kai Lee Yap 1 2, Amy E Knight Johnson 1, David Fischer 1, Priscilla Kandikatla 1, Jacea Deml 1, Viswateja Nelakuditi 1, Sara Halbach 1, George S Jeha 3, Lindsay C Burrage 4, Olaf Bodamer 5, Valeria C Benavides 6, Andrea M Lewis 4, Sian Ellard 7, Pratik Shah 8, Declan Cody 9, Alejandro Diaz 10, Aishwarya Devarajan 5, Lisa Truong 11, Siri Atma W Greeley 12, Diva D De Leon 13, Andrew C Edmondson 14, Soma Das 1, Paul Thornton 11, Darrel Waggoner 1, Daniela Del Gaudio 15 Correction: "Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals"
PMID: 30097611
DOI: 10.1038/s41436-018-0126-1
https://pubmed.ncbi.nlm.nih.gov/30097611/
Ann W McMahon 1, Gerold T Wharton 1, Paul Thornton 2, Diva D De Leon 3 Octreotide use and safety in infants with hyperinsulinism
PMID: 27910218
PMCID: PMC5286465
DOI: 10.1002/pds.4144
https://pubmed.ncbi.nlm.nih.gov/27910218/
Preneet Cheema Brar 1, Ryan Heksch 2, Kristina Cossen 3, Diva D De Leon 4, Manmohan K Kamboj 5, Seth D Marks 6, Bess A Marshall 7, Ryan Miller 8, Laura Page 9, Takara Stanley 10, Deborah Mitchell 10, Paul Thornton 11 Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism
PMID: 32810255
DOI: 10.1210/clinem/dgaa543
https://pubmed.ncbi.nlm.nih.gov/32810255/
Ana Paola De Cosio 1, Paul Thornton 2 Current and Emerging Agents for the Treatment of Hypoglycemia in Patients with Congenital Hyperinsulinism
PMID: 31218604
DOI: 10.1007/s40272-019-00334-w
https://pubmed.ncbi.nlm.nih.gov/31218604/